Sex-related effects of agmatine on caffeine-induced locomotor activity in Swiss Webster mice

European Journal of Pharmacology

Volumn 630, Issue 1-3, 2010, Pages 69-73

  Uzbay, Tayfun ^a   Kose, Akin ^a   Kayir, Hakan ^a   Ulusoy, Gokhan ^a   Celik, Turgay ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Agmatine; Caffeine; Locomotor activity; Mice; Sex difference

Indexed keywords

AGMATINE; CAFFEINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; FEMALE; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SWISS WEBSTER MOUSE;

AGMATINE; ANIMALS; BEHAVIOR, ANIMAL; CAFFEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; MALE; MICE; MOTOR ACTIVITY; RANDOM ALLOCATION; SEX FACTORS;

EID: 77649185390     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.12.020     Document Type: Article

References (55)

1. Antoniou K., Kafetzopoulos E., Papadopoulou-Daifoti Z., Hyphantis T., Marselos M. d-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats. Neurosci. Biobehav. Rev. 1998, 23:189-196.
2. Aricioglu-Kartal F., Uzbay I.T. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci. 1997, 61:1775-1781.
3. Askalany A.R., Yakamura T., Petrenko A.B., Kohno T., Sakimura K., Baba H. Effect of agmatine on heteromeric N-methyl-d-aspartate receptor channels. Neurosci. Res. 2005, 52:387-392.
4. Booze R.M., Welch M.A., Wood M.L., Billings K.A., Apple S.R., Mactutus C. Behavioral sensitization following repeated intravenous nicotine administration: gender differences and gonadal hormones. Pharmacol. Biochem. Behav. 1999, 64:827-839.
5. Celik T., Zagli Ü., Kayir H., Uzbay I.T. Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice. Drug Alcohol Depend. 1999, 56:109-113.
6. Celik E., Uzbay I.T., Karakas S. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:50-55.
7. Craft R.M., Stratmann J.A. Discriminative stimulus effects of cocaine in female versus male rats. Drug Alcohol Depend. 1996, 42:27-37.
8. Daly J.W., Fredholm B.B. Caffeine - an atypical drug of dependence. Drug Alcohol Depend. 1998, 51:199-206.
9. Demehri S., Homayoun H., Honar H., Riazi K., Vafaie K., Roushanzamir F., Dehpour A.R. Agmatine exerts anticonvulsant effect in mice: modulation by alpha 2-adrenoceptors and nitric oxide. Neuropharmacology 2003, 45:534-542.
10. Dunstan R., Jackson D.M. The effect of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol. Clin. Exp. Pharmacol. Physiol. 1977, 4:131-141.
11. 2A receptors. Br. J. Pharmacol. 2000, 129:1465-1473.
12. Evans S.M., Griffiths R.R. Caffeine tolerance and choice in humans. Psychopharmacology 1992, 108:51-59.
13. Evans S.M., Griffiths R.R. Caffeine withdrawal: a parametric analysis of caffeine dosing conditions. J. Pharmacol. Exp. Ther. 1999, 289:285-294.
14. Forgie M.L., Steward J. Sex differences in the locomotor-activating effects of amphetamine: role of circulating testosterone in adulthood. Physiol. Behav. 1994, 55:639-644.
15. Galea E., Regunathan S., Eliopoulos V., Feinstein D.L., Reis D.J. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem. J. 1996, 316(pt 1):247-249.
16. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 1991, 14:60-67.
17. Garthwaite J., Garthwaite G., Palmer R.M., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 1989, 172:413-416.
18. Gong Z.-H., Li Y.-F., Zhao N., Yang H.-J., Su R.-B., Luo Z.-P., Li J. Anxiolytic effect of agmatine in rats and mice. Eur. J. Pharmacol. 2006, 550:112-116.
19. Jurkiewicz N.H., Garcez do Carmo L., Hirata H., da Costa Santos W., Jurkiewicz A. Functional properties of agmatine in rat vas deferens. Eur. J. Pharmacol. 1996, 307:299-304.
20. Kaplan G.B., Greenblatt D.J., Kent M.A., Cotreau-Bibbo M.M. Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding. J. Pharmacol. Exp. Ther. 1993, 226:1563-1572.
21. Kayir H., Uzbay I.T. Evidence for the role of nitric oxide in caffeine-induced locomotor activity in mice. Psychopharmacology 2004, 172:11-15.
22. Kosowski A.R., Cebers G., Cebere A., Swanhagen A.C., Liljequist S. Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551. Psychopharmacology 2004, 175:114-123.
23. Krass M., Wegener G., Vasar E., Volke V. Antidepressant-like effect of agmatine is not mediated by serotonin. Behav. Brain Res. 2008, 188:324-328.
24. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994, 263:966-969.
25. Li Y.F., Gong Z.H., Cao J.B., Wang H.L., Luo Z.P., Li J. Antidepressant-like effect of agmatine and its possible mechanism. Eur. J. Pharmacol. 2003, 469:81-88.
26. Nikodijević O., Jacobson K.A., Daly J.W. Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol. Biochem. Behav. 1993, 44:199-216.
27. Nikolic J., Bjelakovic G., Stojanovic I. Effect of caffeine on metabolism of l-arginine in the brain. Mol. Cell. Biochem. 2003, 244:125-128.
28. Ozdogan U.K., Lähdesmäki J., Hakala K., Scheinin M. The involvement of alpha 2A-adrenoceptors in morphine analgesia, tolerance and withdrawal in mice. Eur. J. Pharmacol. 2004, 497:161-171.
29. Palenicek T., Votava M., Bubenikova V., Horacek J. Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats. Physiol. Behav. 2005, 86:546-553.
30. Parale M.P., Kulkarni S.K. Studies with alpha 2-adrenoceptor agonists and alcohol abstinence syndrome in rats. Psychopharmacology 1986, 88:237-239.
31. Piletz J.E., Chikkala D.N., Ernsberger P. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J. Pharmacol. Exp. Ther. 1995, 272:581-587.
32. Pinthong D., Wright I.K., Hanmer C., Millns P., Mason R., Kendall D.A., Wilson V.G. Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 1995, 351:10-16.
33. Pogun S. Sex differences in brain and behavior: emphasis on nicotine, nitric oxide and place learning. Int. J. Psychophysiol. 2001, 42:195-208.
34. Regunathan S., Reis D.J. Imidazoline receptors and their endogenous ligands. Annu. Rev. Pharmacol. Toxicol. 1996, 36:511-544.
35. Reis D.J., Regunathan S. Agmatine: an endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain. J. Auton. Nerv. Syst. 1998, 72:80-85.
36. Reis D.J., Regunathan S. Agmatine: a novel transmitter?. Adv. Pharmacol. 1998, 42:645-649.
37. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends. Pharmacol. Sci. 2000, 21:187-193.
38. Romero R.D., Chen W.-J.A. Gender-related response in open-field activity following developmental nicotine exposure in rats. Pharmacol. Biochem. Behav. 2004, 78:675-681.
39. Sell S.L., Scalzitti J.M., Thomas M.L., Cunningham K.A. Influence of ovarian hormones and estrous cycle on the behavioral response to cocaine in female rats. J. Pharmacol. Exp. Ther. 2000, 293:879-886.
40. Snyder S.H., Katims J.J., Annau Z., Bruns R.F., Daly J.W. Adenosine receptors and behavioral actions of methylenexanthines. Proc. Natl. Acad. Sci. 1981, 78:3260-3264.
41. Stöhr T., Schulte W.D., Weiner I., Felon J. Rat strain differences in open-field behavior and the locomotor stimulating and rewarding effects of amphetamine. Pharmacol. Biochem. Behav. 1998, 59:813-818.
42. Su R.B., Wei X.L., Zheng J.Q., Liu Y., Lu X.Q., Li J. Anticonvulsive effect of agmatine in mice. Pharmacol. Biocehem. Behav. 2004, 77:345-349.
43. Sukhotina I.A., Zvartau E.E., Danysz W., Bespalov A.Y. Caffeine withdrawal syndrome in social interaction test in mice: effects of the NMDA receptor channel blockers, memantine and neramexane. Behav. Pharmacol. 2004, 15:207-214.
44. Svenningson P., Nomikos G.C., Fredholm B.B. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J. Neurosci. 1995, 15:7612-7624.
45. Svensson A., Carlsson M.L., Carlsson A. Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice. J. Neural. Transm. Gen. Sect. 1995, 101:127-148.
46. Tabor C.W., Tabor H. Polyamines. Annu. Rev. Biochem. 1984, 53:749-790.
47. Ulusu U., Uzbay I.T., Kayir H., Alici T., Karakas S. Evidence for the role of nitric oxide in nicotine-induced locomotor sensitization in mice. Psychopharmacology 2005, 178:500-504.
48. Uzbay I.T., Yeşilyurt O., Celik T., Ergün H., Işimer A. Effects of agmatine on ethanol withdrawal syndrome in rats. Behav. Brain Res. 2000, 107:153-159.
49. Uzbay I.T., Wallis C.J., Lal H., Forster M.J. Effects of NMDA receptor blockers on cocaine-stimulated locomotor activity in mice. Behav. Brain Res. 2000, 108:57-61.
50. Uzbay I.T., Coskun I., Kayir H., Ozturk N., Ozturk Y. Extract of Hypericum perforatum blocks caffeine-induced locomotor activity in mice: a possible role of nitric oxide. Phytother. Res. 2007, 21:415-419.
51. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 1987, 94:469-497.
52. Wolf M.E., Xue C.J. Amphetamine-induced glutamate efflux in the rat ventral tegmental area is prevented by MK-801, SCH 23390, and ibotenic acid lesions of the prefrontal cortex. J. Nerochem. 1999, 73:1529-1538.
53. Yang X.C., Reis D.J. Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J. Pharmacol. Exp. Ther. 1999, 288:544-549.
54. 2-adrenoceptor-mediated mechanism in mice. Neuropsychopharmacology 2001, 25:98-103.
55. Zhu M.Y., Piletz J.E., Halaris A., Regunathan S. Effects of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells. Cell. Mol. Neurobiol. 2003, 23:865-872.